SEC Form 4 · accession 0001055726-17-000001
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Niranjan Sardesai
Officer — Chief Operating Officer
Period of report
Jan 4, 2017
Accepted (ET)
Jan 4, 2017 · 3:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2017 | M | 6,133 | $6.12 | A | 54,567 | D | |
| Common Stock | Jan 4, 2017 | M | 3,680 | $6.12 | A | 58,247 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option | $6.12 | Jan 4, 2017 | M | 6,133 | D | Jan 5, 2010 | Jan 5, 2017 | Common Stock | 6,133 | 0 | D |
| Common Stock Option | $6.12 | Jan 4, 2017 | M | 3,680 | D | Jan 18, 2010 | Jan 18, 2017 | Common Stock | 3,680 | 0 | D |